Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Immunocore Holdings plc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +6 vs. Q2 2023
- Shares held
- 36.9M
- +2.57M (+7.5%) vs. Q2 2023
- Total value
- $1.92B
- −$141.8M (−6.9%) vs. Q2 2023
- New holders
- 14
- 51 more added
- Sold out
- 8
- 37 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TD Asset Management Inc | 301,920 | $15.7M | 0.02% | +158,086+109.9% | Added |
| Massachusetts Financial Services Co | 312,347 | $16.2M | 0.01% | −49,616−13.7% | Reduced |
| Avidity Partners Management LP | 348,200 | $18.1M | 0.73% | −226,800−39.4% | Reduced |
| Armistice Capital, LLC | 400,000 | $20.8M | 0.62% | −28,000−6.5% | Reduced |
| Tang Capital Management LLC | 405,600 | $21.1M | 2.97% | 00.0% | Unchanged |
| Logos Global Management LP | 450,000 | $23.4M | 3.33% | −50,000−10.0% | Reduced |
| Renaissance Technologies LLC | 456,300 | $23.7M | 0.04% | +9,000+2.0% | Added |
| Cowen and Company, LLC | 460,036 | $23.9M | 1.68% | 00.0% | Unchanged |
| Principal Financial Group Inc | 485,886 | $25.2M | 0.02% | +2,129+0.4% | Added |
| Nicholas Investment Partners, LP | 512,855 | $26.6M | 1.99% | +508,155+10,811.8% | Added |
| Bill & Melinda Gates Foundation | 576,923 | $29.9M | 35.70% | 00.0% | Unchanged |
| First Manhattan Co | 613,749 | $31.9M | 0.12% | 00.0% | Unchanged |
| Fiera Capital Corp | 679,799 | $35.3M | 0.11% | +158,502+30.4% | Added |
| BlackRock Inc. | 759,833 | $39.4M | 0.00% | −32,251−4.1% | Reduced |
| Braidwell LP | 906,973 | $47.1M | 1.49% | +438,946+93.8% | Added |
| Pictet Asset Management Holding SA | 910,238 | $47.2M | 0.06% | +910,238 | New |
| General Atlantic LLC | 950,000 | $49.3M | 0.76% | 00.0% | Unchanged |
| Morgan Stanley | 961,088 | $49.9M | 0.01% | +148,466+18.3% | Added |
| Paradigm Biocapital Advisors LP | 1,384,686 | $71.9M | 4.90% | +114,562+9.0% | Added |
| FMR LLC | 2,136,223 | $110.9M | 0.01% | +90,116+4.4% | Added |
| Baker Bros. Advisors LP | 2,520,731 | $130.8M | 0.75% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,521,284 | $130.9M | 0.02% | +97,864+4.0% | Added |
| Rock Springs Capital Management LP | 2,943,710 | $152.8M | 4.09% | −84,700−2.8% | Reduced |
| Wellington Management Group LLP | 3,913,410 | $203.1M | 0.04% | +217,920+5.9% | Added |
| RTW Investments, LP | 6,096,387 | $316.4M | 6.68% | +66,754+1.1% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −45,200−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −16,400−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −3,985−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −3,476−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −522−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |